葡萄糖的临床药理学
Mohamad M Kronfol1, Edwin C Chow1, S W Johnny Lau1
1Office of Clinical Pharmacology, Office of Translational Sciences, Center of Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Clinical pharmacology and therapeutics
|June 7, 2024
概括
胰腺激素葡萄糖调节血糖,具有新兴的治疗潜力. 这篇评论探讨了它的生理学,疾病联系和临床药理学,强调了在治疗肥胖和糖尿病等疾病中的未充分利用的应用.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 代谢疾病 代谢疾病
背景情况:
- 葡萄糖,胰腺α细胞激素,对胰岛素进行反调节,对葡萄糖平衡至关重要.
- 它的生理作用和临床应用,特别是在代谢疾病中,越来越被认可.
- 尽管很重要,但与胰岛素相比,葡萄糖的治疗潜力在历史上未被充分探索.
研究的目的:
- 审查葡萄糖素在人类健康和疾病中的确定的生理作用.
- 总结目前可用的葡萄糖产品和同类药物的临床药理学.
- 突出葡萄糖在药物治疗中的潜力,特别是考虑到肥胖和糖尿病率的上升.
主要方法:
- 对已确定的葡萄糖的生理功能进行文献综述.
- 已批准的葡萄糖产品临床药理学数据的摘要.
- 在人体研究中对药理动力学和药理动力学评估的分析.
主要成果:
- 葡萄糖对荷尔蒙产生显著的调节作用,主要通过肝脏的作用.
- 美国批准了6种葡萄糖产品和1种类似产品.
- 临床药理学研究通过全面的人体评估证实了葡萄糖的作用.
结论:
- 葡萄糖的既定生理作用和与疾病的关系需要进一步研究.
- 了解葡萄糖的临床药理学对于探索其治疗应用至关重要.
- 肥胖和糖尿病的患病率越来越高,强调需要探索葡萄糖的全部临床潜力.
相关概念视频
Hypoglycemia and Glucagon
256
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
256
Glucagon-like Receptor Agonists
316
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
316
Hormones Regulating Blood Glucose
3.2K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.2K
Oral Hypoglycemic Agents: Glinides
152
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
152
Glucose Homeostasis: Regulation of Blood Glucose
1.6K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.6K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.2K


